Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Novartis Pharmaceuticals.
Real, source-linked trial activity for Novartis Pharmaceuticals: 14 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Nov 4, 2026. Source-linked, daily-refreshed.
N/A 7PHASE2 4PHASE3 2PHASE1 1
Newest Novartis Pharmaceuticals trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 8d ago | Factors Influencing Adoption of a Novel Malaria Treatment in Côte d'Iv | N/A | NOT_YET_RECRUITING | ↗ |
| 13d ago | Managed Access Programs for MAS825, Arumakimig | N/A | TEMPORARILY_NOT_AVAILABLE | ↗ |
| 16d ago | A Real-world Study of Treatment Retention and Adherence to Secukinumab | N/A | NOT_YET_RECRUITING | ↗ |
| 26d ago | A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of N | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 33d ago | A Study to Explore the Tissue Level Effects of Remibrutinib in Adults | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 35d ago | A Study of the Efficacy and Safety of Zigakibart + Atrasentan in Adult | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 37d ago | An External Control Arm Study Comparing Survival Among Metastatic Cast | N/A | COMPLETED | ↗ |
| 37d ago | A Study of Disease Modifying Therapy Use in Women With Multiple Sclero | N/A | ACTIVE_NOT_RECRUITING | ↗ |
| 41d ago | A Study of Real-world Use and Effectiveness of Cytoreductive Strategie | N/A | COMPLETED | ↗ |
| 44d ago | Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerabil | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 50d ago | A Real-World Study of Ofatumumab in Multiple Sclerosis Patients in Ger | N/A | ACTIVE_NOT_RECRUITING | ↗ |
| 54d ago | Investigation of a Remibrutinib- and Omalizumab-based Treatment Algori | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 55d ago | Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Ag | Ph 2 | COMPLETED | ↗ |
| 55d ago | Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Ag | Ph 2 | RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Novartis Pharmaceuticals (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.